News & events
Press Releases
On the 28th March 2022, OncoArendi changed its name to Molecure
OncoArendi Therapeutics has entered into a global license agreement with Yale University
10 February 2015
OncoArendi receives a grant of over 7 mln PLN for its lead drug discovery program
14 July 2014
On June 2, 2014 OncoArendi received another grant for IP protection PL
2 June 2014
Events & Presentations
EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018
17 September 2018
54th International Conference on Medicinal Chemistry, Strasbourg, France – July 4-6, 2018.
17 July 2018
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26 – 30, 2017
1 October 2017